Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/β-Catenin Signaling
Crossref DOI link: https://doi.org/10.1371/journal.pone.0094748
Published Online: 2014-04-14
Update policy: https://doi.org/10.1371/journal.pone.corrections_policy
Chien, Andy J.
Haydu, Lauren E.
Biechele, Travis L.
Kulikauskas, Rima M.
Rizos, Helen
Kefford, Richard F.
Scolyer, Richard A.
Moon, Randall T.
Long, Georgina V.
License valid from 2014-04-14